Displaying 241–250 of 304 research results
Aug 4, 2015
40 percent of genetically tested XLRP carriers showed a definitive abnormality in at least one of three visions tests.
Jul 28, 2015
A pioneering, 80-year-old named Ray Flynn is the first AMD patient to receive the Argus II, and he is already reporting that he can see things better in his garden.
Jul 16, 2015
What happens to the brain when the eye is enabled to see through gene therapy? Would the brain and eye restart their partnership? We now know the answer is yes.
Jun 27, 2015
For those of us supporting the drive for vision-saving treatments and cures, he’s exactly the type of person we want on our team.
Jun 26, 2015
Dr. Boye received the Foundation’s Board of Director’s Award, which was presented at VISIONS 2015, FFB’s annual conference, for achievements in retinal research.
May 19, 2015
The mission of the program—to regenerate the neurons and neural connections in the eye and visual system—is synonymous with the Foundation’s mission to eradicate retinal diseases.
May 13, 2015
After years of refinement and testing in animal models, the emerging therapy is about a year and a half from moving into a clinical trial.
May 12, 2015
One of the hot topics at ARVO this year is a rapidly advancing gene-therapy approach called clustered regularly interspaced short palindromic repeats, or CRISPR.
Apr 14, 2015
A primer on what you can expect from clinical trials.
Feb 12, 2015
Dr. Gerald Fishman discusses cystoid macular edema (CME), a potentially damaging accumulation of fluid in the retina affecting up to 32 percent of people with retinitis pigmentosa (RP).